Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Iversen

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Frontiers in Neuroscience|November 19, 2014
Oxidative metabolism of astrocytes is not reduced in hepatic encephalopathy: a PET study with [(11)C]acetate in humansPeter Iversen, Kim Mouridsen, Mikkel B Hansen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 1, 2012
Brain energy metabolism and blood flow differences in healthy agingJoel Aanerud, Per Borghammer, M Mallar Chakravarty, et al.
The Journal of Urology|September 5, 2017
Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup ResultsBertrand Tombal, Michael Borre, Per Rathenborg, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 4, 2017
Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-studyRoni Nielsen, Anders Jorsal, Peter Iversen, et al.
Endocrine-Related Cancer|June 8, 2013
Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapyThine Hvid, Kamilla Winding, Anders Rinnov, et al.
Gastroenterology|December 2, 2008
Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathyPeter Iversen, Michael Sørensen, Lasse Kristoffer Bak, et al.
Scandinavian Journal of Urology and Nephrology|March 8, 2003
Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer -- Scandinavian Prostatic Cancer Group (SPCG) Study No. 5Per Olov Hedlund, Martti Ala-Opas, Einar Brekkan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2021
A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for <sup>68</sup>Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine TumorsIrene Virgolini, Shadfar Bahri, Andreas Kjaer, et al.
European Urology Focus|July 30, 2017
Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control StudyThomas Steuber, Kasper D Berg, Martin A Røder, et al.
The Lancet. Oncology|April 18, 2014
Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 studyBertrand Tombal, Michael Borre, Per Rathenborg, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Frontiers in Neuroscience|November 19, 2014
Oxidative metabolism of astrocytes is not reduced in hepatic encephalopathy: a PET study with [(11)C]acetate in humansPeter Iversen, Kim Mouridsen, Mikkel B Hansen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 1, 2012
Brain energy metabolism and blood flow differences in healthy agingJoel Aanerud, Per Borghammer, M Mallar Chakravarty, et al.
The Journal of Urology|September 5, 2017
Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup ResultsBertrand Tombal, Michael Borre, Per Rathenborg, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 4, 2017
Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-studyRoni Nielsen, Anders Jorsal, Peter Iversen, et al.
Endocrine-Related Cancer|June 8, 2013
Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapyThine Hvid, Kamilla Winding, Anders Rinnov, et al.
Gastroenterology|December 2, 2008
Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathyPeter Iversen, Michael Sørensen, Lasse Kristoffer Bak, et al.
Scandinavian Journal of Urology and Nephrology|March 8, 2003
Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer -- Scandinavian Prostatic Cancer Group (SPCG) Study No. 5Per Olov Hedlund, Martti Ala-Opas, Einar Brekkan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2021
A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for <sup>68</sup>Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine TumorsIrene Virgolini, Shadfar Bahri, Andreas Kjaer, et al.
European Urology Focus|July 30, 2017
Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control StudyThomas Steuber, Kasper D Berg, Martin A Røder, et al.
The Lancet. Oncology|April 18, 2014
Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 studyBertrand Tombal, Michael Borre, Per Rathenborg, et al.
Pageof 16